Press Releases

Date Title and Summary
Toggle Summary Leading Russian Cancer Center Acquires CyberKnife(R) System
Acquisition Marks First Robotic Radiosurgery System in Russia, Expanding Patients' Cancer Treatment Options SUNNYVALE, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the N. N.
Toggle Summary M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
SUNNYVALE, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company is partnering with The University of Texas M. D. Anderson Cancer Center in Houston, Texas to launch a prospective clinical study
Toggle Summary Medical Centers Worldwide Adopt Both Accuray's CyberKnife and TomoTherapy Systems
Provides personalized care to treat the full spectrum of radiation oncology patients SUNNYVALE, Calif. , Dec. 19, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that 23 leading medical centers globally have installed both a
Toggle Summary MedStar Georgetown University Hospital Treats 1,000 Prostate Cancer Patients with the CyberKnife® System
Patients Benefit from Fewer Treatment Sessions and Minimal Side Effects SUNNYVALE, Calif. , March 31, 2016 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that MedStar Georgetown University Hospital in Washington, D.C. treated its 1,000th prostate cancer patient with the
Toggle Summary Mercy Advances Cancer Care in Missouri with Multi-System, Multi-Hospital Agreement for Accuray Radiation Therapy Systems
- One-of-a-kind Accuray Radixact® and CyberKnife® Systems Offer Technological Innovations Designed to Deliver Unique Patient Benefits - Mercy is First in Missouri to Acquire the Radixact and CyberKnife M6™ Systems SUNNYVALE, Calif. , May 9, 2018 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY)
Toggle Summary Miami Cancer Institute Treats First Cancer Patients with the Accuray Radixact™ System
Day 1 Experience Demonstrates the Speed and Efficiency of the New System SUNNYVALE, Calif. , Jan. 26, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Miami Cancer Institute , a part of Baptist Health South Florida, is now treating patients using the new, uniquely
Toggle Summary Mika Nishimura Joins Accuray Board of Directors
SUNNYVALE, Calif. , Aug. 23, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Mika Nishimura to the company's Board of Directors, effective as of August 17, 2021 . With Ms. Nishimura's appointment, the Accuray Board will consist of nine members. Ms.
Toggle Summary Montefiore is First in NY Metropolitan Area to Treat Cancer Patients with Accuray Radixact™ System
Cutting-Edge Radiation Therapy System Dramatically Improves Precision, Efficiency and Safety, While Minimizing Side Effects SUNNYVALE, Calif. and NEW YORK , June 27, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) and Montefiore Einstein Center for Cancer Care (MECCC), part of the
Toggle Summary More than 100 Presentations at Leading Radiation Oncology Meeting Demonstrate High Value and Broad Utilization of Accuray's Treatment Platforms
Data Supports Growing Use of CyberKnife® SBRT for Prostate Cancer SUNNYVALE, Calif. , Oct. 3, 2013 /PRNewswire/ -- ASTRO 2013 ( Atlanta ) – Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting in
Toggle Summary Mount Vernon Cancer Centre Becomes First NHS Facility to Acquire a CyberKnife System
Government Purchase Enhances Patient Access to Whole Body Radiosurgery SUNNYVALE, Calif., Feb 15, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Mount Vernon Cancer Centre in the United Kingdom has become the

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.